Quantamental Technologies LLC Sage Therapeutics, Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $210,687 - $263,260	5,653 New	5,653 $237,000
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $274,527 - $418,582	-4,700 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $28,791 - $43,715	-700 Reduced 12.96%	4,700 $287,000
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $140,130 - $233,010	5,400 New	5,400 $225,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.